4-(4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-8-fluoro-2-(((2R,7aS)-2-fluorohexahydro-1H-pyrrolizin-7a-yl)methoxy)pyrido[4,3-d]pyrimidin-7-yl)-5,6-difluoronaphthalen-2-ol

ID: ALA4874297

PubChem CID: 156124898

Max Phase: Preclinical

Molecular Formula: C31H30F4N6O2

Molecular Weight: 594.61

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Oc1cc(-c2ncc3c(N4CC5CCC(C4)N5)nc(OC[C@@]45CCCN4C[C@H](F)C5)nc3c2F)c2c(F)c(F)ccc2c1

Standard InChI:  InChI=1S/C31H30F4N6O2/c32-17-10-31(6-1-7-41(31)12-17)15-43-30-38-28-22(29(39-30)40-13-18-3-4-19(14-40)37-18)11-36-27(26(28)35)21-9-20(42)8-16-2-5-23(33)25(34)24(16)21/h2,5,8-9,11,17-19,37,42H,1,3-4,6-7,10,12-15H2/t17-,18?,19?,31+/m1/s1

Standard InChI Key:  DPNHZGPOIOCMPM-XWRDYELXSA-N

Molfile:  

 
     RDKit          2D

 43 50  0  0  0  0  0  0  0  0999 V2000
   21.4189  -14.9210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1373  -14.1404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3116  -14.1702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7646  -15.4272    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.0823  -14.9658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4326  -15.4722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7135  -16.2465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5366  -16.2186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2144  -14.9700    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9327  -14.5556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9299  -13.7229    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2126  -13.3128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4978  -14.5561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5019  -13.7266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7896  -13.3105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0686  -13.7194    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0644  -14.5489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7813  -14.9696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3496  -14.9579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9118  -15.7748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6306  -16.1926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3460  -15.7817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9173  -14.9469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6345  -14.5429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6422  -13.7215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9334  -13.3033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2154  -13.7124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2112  -14.5324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6286  -17.0198    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.7783  -15.7967    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   18.6496  -14.9681    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.3653  -14.5534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2094  -12.4857    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9278  -12.0734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9266  -11.2498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2105  -10.8352    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.4941  -11.2503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4936  -12.0800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9056  -11.7466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4695  -11.7466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2502  -16.9317    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.3623  -13.3147    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.9396  -12.4763    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  4  1  1  0
  1  2  1  0
  2  3  1  0
  3  5  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  4  1  0
 13  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 14  1  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 19 24  2  0
 23 20  2  0
 20 21  1  0
 21 22  2  0
 22 19  1  0
 17 19  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 21 29  1  0
 18 30  1  0
 10 31  1  0
 31 32  1  0
  5 32  1  1
 12 33  1  0
 33 34  1  0
 33 38  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 37 39  1  0
 35 40  1  0
 39 40  1  0
  7 41  1  6
 25 42  1  0
 26 43  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4874297

    ---

Associated Targets(Human)

KRAS Tclin GTPase KRas (1864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 594.61Molecular Weight (Monoisotopic): 594.2366AlogP: 4.86#Rotatable Bonds: 5
Polar Surface Area: 86.64Molecular Species: BASEHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.16CX Basic pKa: 9.85CX LogP: 4.23CX LogD: 2.31
Aromatic Rings: 4Heavy Atoms: 43QED Weighted: 0.32Np Likeness Score: -0.15

References

1. Kargbo RB..  (2021)  Targeting KRAS G12D Mutant for the Potential Treatment of Pancreatic Cancer.,  12  (11.0): [PMID:34795853] [10.1021/acsmedchemlett.1c00545]

Source